Orofino Pharmaceuticals Group

P.I. 09904 (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£1,346,909

Jun 22 - Jun 26

MICA: Developing a rectal formulation of ceftriaxone for community-based management of neonatal sepsis in low- and middle-income countries

MRC award to University of Oxford and Elizabeth Ashley

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}